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Abstract
In this paper we aim to create a reference data collection of Northern blot results
and demonstrate how such a collection can enable a quantitative comparison of
modern expression proﬁling techniques, a central component of functional genomics
studies. Historically, Northern blots were the de facto standard for determining RNA
transcript levels. However, driven by the demand for analysis of large sets of genes in
parallel, high-throughput methods, such as microarrays, dominate modern proﬁling
efforts. To facilitate assessment of these methods, in comparison to Northern blots,
we created a database of published Northern results obtained with a standardized
commercial multiple tissue blot (dbMTN). In order to demonstrate the utility of the
dbMTN collection for technology comparison, we also generated expression proﬁles
for genes across a set of human tissues, using multiple proﬁling techniques. No method
produced proﬁles that were strongly correlated with the Northern blot data. The
highest correlations to the Northern blot data were determined with microarrays
for the subset of genes observed to be speciﬁcally expressed in a single tissue in
the Northern analyses. The database and expression proﬁling data are available
via the project website (http://www.cisreg.ca). We believe that emphasis on multi-
technique validation of expression proﬁles is justiﬁed, as the correlation results
between platforms are not encouraging on the whole. Supplementary material for this
article can be found at: http://www.interscience.wiley.com/jpages/1531-6912/suppmat
Copyright  2005 John Wiley & Sons, Ltd.
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Introduction
Technologies to monitor gene expression are abun-
dant, and have been widely applied to character-
ize genes and to analyse expression at a genome
scale [1,2]. Most approaches are based on the
determination of mRNA abundance, which serves
as a ﬁrst approximation for the strength of a
gene’s expression in a cell or tissue sample.
Despite this common basic principle of expression
proﬁling techniques, each exhibits distinct strengths
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and weaknesses that render certain techniques
preferable, depending on the scientiﬁc goal. Tech-
nically, the diverse methods for transcript proﬁling
can be broadly categorized into three distinct sets:
(a) hybridization-based; (b) sequencing-based; and
(c) PCR-based.
Historically, transcript levels of newly cloned
genes have been assessed primarily with North-
ern blots, which remain a popular but nonethe-
less labour-intensive hybridization-based technique
for the analysis of individual genes. For the
study of large sets of genes required in genomics,
transcript levels are often monitored by array-
based hybridization methods. Several variations
on high-throughput arrays have been developed,
including cDNA macroarrays on nylon ﬁlters,
cDNA microarrays on glass, and oligonucleotide
arrays [3–5]. Despite their popularity, questions re-
main about the capacity of array-based methods
to assess accurately the level of gene expression
in terms of linearity between signal and expres-
sion [6].
Sequencing-based methods measure transcript
frequency within cDNA or SAGE libraries [7,8].
These highly comprehensive approaches allow the
detection of unexpected transcripts and therefore
make valuable contributions to gene discovery [9].
However, a major drawback for the most acces-
sible tag data, the analysis of EST sequences, are
normalization procedures used in the construction
of many cDNA libraries, which result in non-
quantitative data.
PCR-based approaches are used extensively
for expression proﬁling of small sets of genes.
RT-PCR is a sensitive and powerful tool for
the semi-quantitative analysis of relative tran-
script levels [10]. Quantitative approaches, such as
TaqMan, have been developed for detailed studies
of single genes [11], but high-throughput analysis
is prohibitively expensive in terms of both labour
and reagents.
Given the plethora of competing proﬁling meth-
ods available to researchers, it is essential to deter-
mine their respective merits and faults by compar-
ison to standard sets of gene expression proﬁles.
To date, there have been a limited number of pair-
wise comparisons of expression proﬁling technolo-
gies [1,2,4,12–14], but no broad cross-platform
studies have been reported. A signiﬁcant require-
ment for conducting multi-platform comparisons is
a suitable reference collection. For newly cloned
human genes, a de facto standard for expression
proﬁling has emerged — multiple tissue Northern
blots. In fact, most reports speciﬁcally characteriz-
ing a novel gene include a ﬁgure with a common
format of multiple tissue Northern blots generated
by a single commercial supplier (ClonTech). Thus,
within the scientiﬁc literature there exists a large
collection of peer-reviewed reference data describ-
ing the expression of human genes.
We report the creation of a database of published
multiple tissue Northern blot results and demon-
strate how such a database can facilitate compar-
ison of expression proﬁles generated with diverse
experimental platforms. First, we describe the pro-
cedures used to extract the published results from
the literature, including the identiﬁcation of arti-
cles, the densitometry of blot images, and the for-
mat of the data collection (dbMTN). By using RNA
from the same commercial source, we were able
to generate expression proﬁles with multiple tech-
niques for comparison to the reference Northern
data. We show the procedures and generate corre-
lation scores describing the similarity between the
proﬁles obtained with the different methods. The
Northern blot reference collection, as well as our
collection of proﬁles and protocols from diverse
methods, are available for further analysis via an
in-depth website.
Materials and methods
Database of results from ClonTech multiple
tissue Northern blots
A database of expression proﬁles produced from
Northern blots has been collected from publica-
tions utilizing common commercial multiple tissue
ﬁlters. A curated list of articles containing MTN
Northern blots (ClonTech) was obtained from the
manufacturer. Each blot contains mRNA recovered
from eight human tissues. With permission from
the publishers, images were downloaded from the
three journals with the greatest number of MTN-
containing papers. These included Genomics (547
blots for 221 genes), Journal of Biological Chem-
istry (693 blots for 265 genes) and Proceedings
of the National Academy of Sciences of the USA
(155 blots for 67 genes). Images were analysed
using the Gel-Pro Plus package (Media Cybernet-
ics). A relative pattern of expression for each band
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(speciﬁc transcript in a single tissue) was gener-
ated by subtracting the highest density observed in
band-free lanes and the vector was normalized to
unit length. All data were reviewed to conﬁrm that
the recorded patterns of expression were consis-
tent with the observed bands on the blots, and each
transcript was annotated with an ofﬁcial identiﬁer
to facilitate future analysis.
Oligonucleotides
PCR primers were designed using the MEDUSA
program [21]. Gene-speciﬁc primer pairs preferen-
tially ﬂanked introns or overlapped splice junc-
tions to decrease the likelihood of obtaining RT-
PCR products from genomic DNA. HPLC-puriﬁed
oligonucleotides were purchased from Interactiva
Biotechnologie GmbH.
RNA
Five tissues were selected for analysis: heart, brain,
lung, liver, and skeletal muscle. To ensure unifor-
mity, all RNA samples were purchased from Clon-
Tech. The commercial preparations were generated
from pools of tissue samples from multiple individ-
uals. Total RNA for RT-PCR was treated with DNA
Free (Ambion) to eliminate residual genomic DNA.
The Northern blots obtained from several years of
biological literature were generated with different
pools of RNA isolated with the same production
process.
Analysis of nucleic acid preparations
A BioAnalyser 2100 (Agilent Technologies) was
employed for quality control of total and poly
A+ RNA and for the analysis of RT-PCR prod-
ucts. RNA samples were loaded onto ‘RNA chips’
(RNA 6000 kit, Agilent) and analysed. In addi-
tion to the determination of both molecular size
and concentration for deﬁned bands, the analysis
provides measures for RNA degradation and con-
tamination by either genomic DNA or ribosomal
RNA. DNA samples, e.g. PCR products for spot-
ting onto arrays, were analysed with the DNA 500
assay (Agilent). Results acquired from these assays
provide an accurate and consistent depiction of the
molecular weight of observed bands, from which
we were able to determine density ratios of back-
ground (alternative) bands to the expected product
for each sample.
RT-PCR
Total RNA was reverse transcribed in the pres-
ence of an oligo(dT)20 primer, using avian RNase
H-minus reverse transcriptase (ThermoScript RT-
PCR System, Life Technologies). PCR reactions
were performed on single-stranded cDNA in the
presence of speciﬁc primer pairs. Reactions (25 µl)
included AmpliTaq Gold DNA polymerase with
the corresponding GeneAmp 10× PCR Buffer
(PE Biosystems) and a MgCl2 concentration of
2.3 mM. The cycle settings were as follows: 95 ◦C
for 10 min, 33 cycles of 95 ◦C for 15 s, 60 ◦C for
30 s and 72 ◦C for 45 s. At the conclusion, a ﬁnal
extension was performed at 72◦C for 7 min. PCR
products were separated on 2% agarose gels.
Ampliﬁcation of cDNA for ﬁlter and cDNA
array spotting
Two pools containing total RNA from human
fetal brain and human testis or HeLa cells and
human placenta were reverse transcribed under
the conditions described above. PCR reactions
(50 µl) were performed with the above conditions
over 42 cycles. PCR products were puriﬁed using
the QIAquick PCR Puriﬁcation Kit (Qiagen) and
analysed on the BioAnalyser.
Filter macroarrays
Array construction
0.5 µl denatured PCR products containing 5 ng
DNA were printed in duplicate onto positively
charged nylon membranes (Roche), using a robotic
dispenser (Hydra, Robbins Scientiﬁc). The DNA
was cross-linked to the membranes (Stratalinker,
Stratagene).
Probe synthesis
Complex probes were labelled with [α32P]-dCTP,
using a reverse transcription reaction (SuperScri-
pt, Life Technologies). Methods for simultaneous
labelling and ﬁrst strand cDNA synthesis were
performed according to the following protocol.
1 µg mRNA in the presence of oligo(dT)18 was
heated to 70 ◦C for 5 min and cooled on ice. Next,
the mixture was incubated at 42 ◦C for 1 h in the
presence of 50 mM Tris–HCl, 75 mM KCl, 3 mM
MgCl2,1 0m M DTT, 500 µM each dATP, dGTP,
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dTTP, 20 µM dCTP, 50 µCi [α32P]-dCTP and 200
U SuperScript II reverse transcriptase. After 1 h,
reactions were terminated at 70 ◦C for 15 min. For
RNA removal, reactions were incubated with 2
U RNase H at 37 ◦C for 20 min. Unincorporated
nucleotides were removed by ﬁltration through
Sephadex G50 columns (Amersham Pharmacia
Biotech). Speciﬁc activity was determined to be
2 × 107cpm/µl for each probe.
Hybridization
Prior to hybridization, membranes were rinsed in
2× SSC at room temperature and pre-hybridized
with 10 ml PerfectHyb (Sigma) for 1 h at 65◦C.
Labelled probes were denatured at 95◦C for 5 min
and cooled on ice. Probes were mixed with 5 ml
hybridization solution and incubated with mem-
branes overnight at 65 ◦C. High stringency washes
were carried out at 65 ◦C for 20 min. Membranes
were washed twice in 2× SSC, 0.1% SDS. A ﬁnal
wash was performed in 0.25× SSC, 0.1% SDS.
Data acquisition
Images were captured by exposure to an imaging
plate (Fuji) for 24 h, and spot intensities deter-
mined (MediaCybernetics Gel-Pro package).
Oligonucleotide arrays
For the Affymetrix (Santa Clara, CA) HuGeneFL
GeneChip (Hu6800, precursor of Human U95A
GeneChip), reverse transcription, cDNA synthe-
sis, labelling and data analysis were performed
as described [22]. The default settings of the
Affymetrix GeneChip 3.1 software were used to
generate the average differences for this study. Pub-
licly available oligonucleotide array data for Clon-
Tech RNA applied to Affymetrix U95A GeneChips
were downloaded for analysis from the Genomics
Institute of the Novartis Research Foundation [16].
cDNA microarrays — double-channel
Spotting
The microarrays were printed with a QArray
(Genetix) instrument with 16 SMP2.5 pins (Tele-
chem) on Ultra GAPS slides (Corning). The 3600
cDNA fragments were spotted in 50% DMSO in
triplicate in three separate ﬁelds, in a 15 × 15 pat-
tern within each block and with a feature centre-
to-centre distance of 290 µm. The quality of the
spotted slides was assessed by staining with Syto61
(Molecular Probes). The slides were UV cross-
linked at 250 mJ/cm2, followed by baking at 75 ◦C
for 2 h, and post-processed with succinic anhy-
dride/sodium borate solution.
In vitro transcription, labelling, and hybridization
The detailed protocols can be found on the web.
For each single array experiment with distinguish-
able ﬂuorescent dye labels for the individual RNAs,
total RNA originating from one of the ﬁve tissues
brain, heart, liver, lung and skeletal muscle was
labelled during reverse transcription with either
Cy3- or Cy5-labelled dUTP. A Universal Human
Reference RNA (Stratagene) was labelled accord-
ingly and used in all hybridizations.
cDNA microarrays — single channel
Spotting
PCR products were puriﬁed with the QIAquick
PCR Puriﬁcation Kit (Qiagen), eluted with water,
dried, and resuspended in 50% DMSO in water
at a concentration of 100–200 ng/µl (as measured
with an Agilent BioAnalyser). The products were
spotted (417 Arrayer, Affymetrix-GMS) onto
CMT-GAPS amino silane coated slides (Corning)
with 40–45% relative humidity at 22 ◦C. Samples
were printed in triplicate. Slides were cross-linked
(Stratalinker, Stratagene) with 65 mJ, followed by
baking at 80 ◦Cf o r2h .
Hybridization
Labelled cDNA was generated with the CyScribe
First-Strand cDNA Labelling Kit (Amersham Phar-
macia Biotech). 1 µg mRNA from each tissue was
reverse transcribed in the presence of ‘anchored’
oligo(dT), random primer and Cy3-labelled dUTP,
followed by degradation of RNA, neutralization
and puriﬁcation. The reverse-transcribed cDNA
was mixed with 20 µg Cot-1 human DNA (Invit-
rogen), and mixed with 20 µg yeast tRNA (Invit-
rogen) and 20 µg pd(A)40–60 (Amersham Pharma-
cia Biotech). Hybridizations were performed using
labelled cDNA dissolved in a total volume of 25 µl
3.4× SSC, 0.3% SDS, at 65 ◦C for 15–18 h. After
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hybridization, the slides were washed at room tem-
perature for 3 min each in 1× SSC, 0.03% SDS,
0.2× SSC, and 0.1× SSC. The slides were dried
with N2 gas and imaged with an Affymetrix 418
scanner (Affymetrix, Santa Clara, CA). Spot inten-
sities were determined using the ArrayVision soft-
ware package (Imaging Research Inc.).
E-Northerns
Electronic Northern analysis [7] was based on
the analysis of EST sequences annotated in the
corresponding UniGene database record for each
gene (http://www.ncbi.nlm.nih.gov/UniGene/).
Data analysis
ClonTech Northern blots
Band intensities for the target tissues were obtained
from the Northern blot database. Unit vectors were
created by dividing the band intensity for each
tissue by the sum of all tissue values. In a few
cases, there was no expression observed in the tar-
get tissues, and these vectors were deﬁned as ‘null’
vectors. A portion of Northern blots displayed mul-
tiple bands (alternative transcripts). These were
excluded unless the transcripts exhibited near-
identical expression proﬁles (square root of sum of
squares < 0.15). For those cases where expression
was near-identical, the mean proﬁle was used.
RT-PCR
RT-PCR products were separated on agarose gels,
an image captured, and the band intensities deter-
mined with the Gel-Pro software. For background
correction, we subtracted the average empty lane
value plus two standard deviations.
Filter macroarrays
Intensity values from each hybridization (tissue)
were normalized with reference to the median.
Two distributions were apparent within the spot
intensities for each ﬁlter (http://www.cisreg.ca).
The distribution of lower values was judged to be
consistent with background. Values were corrected
for background by subtraction of the average
of the background distribution plus two standard
deviations.
Oligonucleotide arrays
Calculations were based on the ‘Average Differ-
ence Value’ from the Affymetrix analysis soft-
ware. For HuGeneFL GeneChips (Hu6800) and the
Human U95A chips, average values were calcu-
lated for each tissue. Intensities were normalized
by rescaling the entire data set in reference to a
chosen baseline array. For both datasets, all val-
ues less than 20 were set to 20. Unit vectors were
generated from the normalized data.
cDNA microarrays — double-channel
Average intensities (with no background correc-
tion) of the triplicate spots were used for analysis.
Background correction may reduce bias of ratios
toward one, but at the cost of adding noise; here
the variation in ratios was judged high enough, and
the range of local background was low enough, that
the decision was made to minimize noise. Accord-
ing to published procedures [23], for each array, a
normalization factor N was calculated by summing
the measured intensities in both channels. In order
to exclude the inﬂuence of extreme values, inten-
sity values determined for the middle 66% of data
points for each array were used to determine N.
The data from one channel was scaled appropri-
ately, and normalized expression ratios were trans-
formed into logarithm base 2. All six arrays per
tissue were averaged to obtain a single value per
tissue per gene. Unit vectors were generated from
the normalized and averaged data.
cDNA microarrays — single-channel
Average intensities of the triplicate spots were used
for analysis. In order to exclude extreme values,
data were normalized to the average intensity
values determined for the middle 66% of data
points for each array. Unit vectors were generated
from the normalized data.
E-Northerns
Subsets of the cDNA libraries used for genera-
tion of ESTs in the global database were iden-
tiﬁed which corresponded to the ﬁve target tis-
sues, and the number of ESTs derived from
these libraries was determined for each gene. The
libraries assigned to each tissue are indicated on
the website (http://www.cisreg.ca). The raw EST
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counts were converted to percentages of the total
number of ESTs produced from each library pool.
Results
Northern blot database — characteristics and
format
Commercial multiple tissue Northern blots have
been extensively used to proﬁle expression of
newly cloned genes. Two speciﬁc blots (MTN,
ClonTech, product numbers 7759-1 and 7760-
1) dominate the scientiﬁc literature, each bear-
ing RNA from eight tissues (7759-1: spleen, thy-
mus, prostate, testis, ovary, small intestine, colon,
peripheral blood leukocyte; 7760-1: heart, brain,
placenta, lung, liver, skeletal muscle, kidney, pan-
creas). Image analysis was performed on a large
collection of published Northern blots to generate
a vector of relative abundances within each tis-
sue for each transcript (deﬁned by size). A total
of 619 blots that addressed 535 distinct genes were
analysed. Expression proﬁles for an average of 1.3
transcripts/gene were captured.
The dbMTN database containing the analysis
results is available as an open-access resource
for the public. A basic search engine is pro-
vided to enable researchers with their own mul-
tiple tissue Northern (MTN) results to search
for human genes with similar expression pro-
ﬁles. dbMTN is available for downloading as a
ﬂat ﬁle consisting of 1398 tab-delimited rows, in
which each row contains the proﬁle for a tran-
script obtained with the indicated blot type. The
data ﬁelds (columns) include transcript identiﬁers,
GenBank accessions, GeneLynx accessions [15]
(http://www.genelynx.org), bibliographic infor-
mation, MTN blot type, and the relative abundance
of the transcript across eight tissues. These ‘scaled’
values are provided, rather than raw band densities
that cannot be compared between blots generated
with probes of different intensities. Hyperlinks are
provided to the original publications. The database
and web interface are formatted to allow future
acquisition of results from a new 12 tissue MTN
product (product number 7780-1) that is gaining
popularity.
Genes with uniform expression across diverse
tissues can serve as valuable controls. There-
fore, we identiﬁed genes with the most uniform
expression across the 16 tissues represented on
the two types of MTN blots. Four genes stood
out as potentially appropriate loading controls for
laboratory experiments: ACTB (actin, beta), AS3
(androgen-induced proliferation inhibitor), GAPD
(glyceraldehyde-3-phosphate dehydrogenase), and
GRB2 (growth factor receptor-bound protein 2).
These genes were redundantly represented in the
dbMTN collection and variation across the tissues
was low for at least one transcript of each gene
(data not shown). In addition to the transcript show-
ing little variation across multiple tissues, ACTB
and GAPD both produce highly expressed muscle-
speciﬁc transcripts, which have not reduced their
popularity as controls.
Correlation analysis of MTN and microarray
expression proﬁles
We compared expression proﬁles produced with
ClonTech human RNA on multiple platforms. We
generated proﬁles with HuGeneFL oligo arrays
(Affymetrix, 7129 probes) and spotted cDNA
microarrays (2608 probes), and incorporated exter-
nal data for U95A oligo arrays (Affymetrix, 12600
probes). ClonTech RNA samples from brain, heart,
liver and lung were used on all of the platforms. In
order to measure the correlation between the large-
scale microarray-generated proﬁles and the MTNs,
we generated unit vectors for each gene’s expres-
sion across the four tissues (as described in Meth-
ods). Correlation scores were calculated between
the broadest possible intersections of genes for each
pair-wise comparison (Table 1). Pearson correla-
tion coefﬁcients (PCCs) for pair-wise intersections
of the three different microarray platforms, com-
pared to Northern blots, were very similar and,
overall, poor.
Given the diverse characteristics of the tech-
niques and genes, different sub-groupings of the
data can provide informative measures to iden-
tify potential strengths or weaknesses of the tech-
niques. Genes were classiﬁed by the overall mag-
nitude of expression based on total UniGene EST
(expressed sequence tags) counts to reveal poten-
tial issues regarding sensitivity and/or dynamic
range of the hybridization-based methods. When
the data were classiﬁed according to the magni-
tude of expression, a performance difference could
be observed between the cDNA microarrays and
the two oligonucleotide arrays. For genes with
low expression (low ESTs), results from the oligo
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Table 1. Correlation coefﬁcients reﬂecting similarity
between the results obtained from microarray-based
methods and Northern blots by analysing different levels
of expression
Northern
cDNA
array
Oligo array
(Hu6800)
All
Northern —
cDNA array 0.36 (93) —
Oligo array (Hu6800) 0.42 (288) 0.45 (1091) —
GNF oligo array 0.35 (312) 0.44 (1305) 0.54 (2251)
(U95A)
High EST
Northern —
cDNA array 0.45 (23) —
Oligo array (Hu6800) 0.28 (72) 0.55 (273) —
GNF oligo array 0.29 (78) 0.50 (326) 0.56 (563)
(U95A)
Middle EST
Northern —
cDNA array 0.35 (47) —
Oligo array (Hu6800) 0.46 (144) 0.45 (545) —
GNF oligo array 0.36 (156) 0.43 (653) 0.55 (1125)
(U95A)
Low EST
Northern —
cDNA array 0.26 (23) —
Oligo array (Hu6800) 0.49 (72) 0.33 (273) —
GNF oligo array 0.40 (78) 0.35 (326) 0.52 (563)
(U95A)
Pearson correlation coefﬁcients were obtained in pair-wise
comparisons of the relative expression levels between genes
originating from the largest possible intersections between methods
(number of genes considered in each comparison indicated in
parentheses). Subsets of genes with different levels of expression
were analysed according to the number of ESTs for each gene,
(GNF = Genomics Institute of the Novartis Research Foundation).
Additional ﬁgures are shown in the on-line supplementary material
displaying scatter plots of the individual gene–gene correlations in
each tissue and across all tissues.
arrays were better correlated with the MTN results,
which may suggest superior sensitivity. At the high
EST level, cDNA arrays performed slightly better,
which points to potential quenching of the ﬂuo-
rescence signal for oligonucleotide arrays at high
expression levels.
Correlation analysis for a pre-selected set of
genes — gene selection
In order to further explore the variation in per-
formance for genes with different characteristics
and to extend the analysis to other common
methods including low-throughput approaches, we
selected a set of 49 well-characterized human genes
for subsequent analyses (gene IDs provided on
website). The selection of these 49 genes was
based on their presence both in the Northern
blot database (dbMTN) and on the Affymetrix
HuGeneFL oligonucleotide array. We focused on
groups of genes representing different classes of
expression based on the Northern blot results (blot
type 7760-1) across ﬁve tissues targeted for labora-
tory analysis (heart, brain, lung, liver and skeletal
muscle): broad (expression observed in at least
three tissues), selective (expression in two tissues),
speciﬁc (expression only in a single tissue) and
‘null’ (no expression detected in the target tissues
on the 7760-1 MTN blot). Positions of the genes
on the array were random and were not taken into
consideration during the selection process or during
subsequent proﬁling with other array-based meth-
ods.
Expression proﬁles from high- and low-
throughput techniques
Expression proﬁles were determined across the tar-
get tissues for the 49 selected genes. New pro-
ﬁles were produced for this report using Clon-
Tech RNA via RT-PCR, ﬁlter macroarrays, single-
channel and double-channel cDNA microarrays,
and an oligonucleotide array (Affymetrix Hu6800).
Published data were included in the analysis
for oligonucleotide microarrays (GNF, Affymetrix
U95A) [16] and ‘Electronic Northerns’ (dbEST),
based on EST counts for each gene [17]. The U95A
microarray results generated with ClonTech RNA
were only available for four of the target tissues
(heart, brain, lung and liver). While gene content
was highly uniform, for some techniques individ-
ual genes were absent (e.g. three genes could not
be ampliﬁed in the RT-PCR study with multiple
primer pairs). The full datasets can be found on
the project website.
After processing, data comprising all ﬁve tissues
and the 49 genes were represented as unit vec-
tors describing the relative pattern of expression
across the target tissues (Figure 1). The expres-
sion proﬁles were split into the above-mentioned
classes based on the breadth of gene expression
in the Northern blots. Within the categories, genes
were sorted by decreasing magnitude of expres-
sion based on total EST counts (i.e. from highest
to lowest within each category).
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GRB2
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2 Hu6800 oligo array
3 cDNA microarray (sc)
4 RT-PCR
5 E-Northern
6 cDNA filter array
SPECIFIC BROAD
123456
Figure 1. Relative expression levels for 49 genes in ﬁve tissues. Pie-charts are presented with the fraction of observed
expression displayed for each of ﬁve target tissues. The genes are categorized based on the breadth of expression observed
in published Northern blots across the ﬁve tissues analysed in this study. Within each category, the genes are ordered
from highest magnitude of expression to the lowest, where the magnitude refers to the total number of EST sequences in
dbEST for each gene. Each gene is identiﬁed by its ofﬁcial HUGO gene symbol (sc = single channel)
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Table 2. Correlation coefﬁcients reﬂecting similarity between the results obtained from different methods by analysing
patterns of expression of a selected set of genes
Northern
Oligo array
(Hu6800)
GNF oligo
array (U95A)
cDNA
array — dc
cDNA
array — sc RT-PCR E-Northern
All
Northern —
Oligo array (Hu6800) 0.50 (49) —
GNF oligo array (U95A) 0.36 (39) 0.51 (38) —
cDNA array — dc 0.61 (16) 0.67 (16) 0.56 (13) —
cDNA array — sc 0.43 (48) 0.57 (48) 0.52 (38) 0.77 (15) —
RT-PCR 0.37 (45) 0.42 (45) 0.31 (36) 0.18 (14) 0.22 (45) —
E-Northern 0.25 (49) 0.29 (49) 0.38 (39) 0.18 (16) 0.21 (48) 0.32 (45) —
Macro array 0.21 (48) 0.39 (48) 0.20 (38) 0.38 (15) 0.23 (48) 0.26 (45) 0.16 (48)
Speciﬁc
Northern —
Oligo array (Hu6800) 0.65 (17) —
GNF oligo array (U95A) 0.56 (12) 0.71 (12) —
cDNA array — dc Na Na Na —
cDNA array — sc 0.53 (17) 0.77 (17) 0.62 (12) Na —
RT-PCR 0.51 (16) 0.53 (16) 0.35 (11) Na 0.26 (16) —
E-Northern 0.40 (17) 0.47 (17) 0.58 (12) Na 0.40 (17) 0.53 (16) —
Macro array 0.37 (17) 0.44 (17) 0.41 (12) Na 0.40 (17) 0.37 (16) 0.34 (17)
Selective
Northern —
Oligo array (Hu6800) 0.57 (10) —
GNF oligo array (U95A) 0.26 (10) 0.49 (9) —
cDNA array — dc Na Na Na —
cDNA array — sc 0.31 (9) 0.49 (9) 0.45 (9) Na —
RT-PCR 0.40 (9) 0.38 (9) 0.48 (9) Na 0.16 (9) —
E-Northern 0.16 (10) 0.30 (10) 0.20 (10) Na 0.25 (9) 0.27 (9) —
Macro array 0.33 (9) 0.58 (9) 0.31 (9) Na 0.22 (9) 0.23 (9) 0.30 (9)
Broad
Northern —
Oligo array (Hu6800) 0.18 (12) —
GNF oligo array (U95A) −0.42 (9) 0.22 (9) —
cDNA array — dc Na Na Na —
cDNA array — sc 0.50 (12) 0.40 (12) 0.43 (9) Na —
RT-PCR 0.34 (12) 0.21 (12) 0.03 (9) Na 0.53 (12) —
E-Northern 0.02 (12) −0.11 (12) 0.26 (9) Na 0.04 (12) −0.10 (12) —
Macro array −0.35 (12) 0.12 (12) −0.73 (9) Na 0.01 (12) 0.19 (12) −0.40 (12)
Pearson correlation coefﬁcients were obtained in comparisons of the relative expression levels between selected sets of genes. Number of
genes considered in each comparison indicated in parentheses (dc = Double-channel; sc = single-channel; GNF = Genomics Institute of the
Novartis Research Foundation).
Correlation of expression data between
techniques for selected gene set
In order to assess the similarity of the results
obtained with different techniques, PCCs were cal-
culated for every pair-wise comparison between
techniques (Table 2). Similar correlation analyses
were performed with Spearman Rank-Order coefﬁ-
cients (http://www.cisreg.ca). All of the statistical
assessments led to qualitatively equivalent results.
For the entire set of genes, microarray-based
expression proﬁling techniques and RT-PCR corre-
lated best with Northern blots. When the data were
categorized according to the pattern of expression
on Northerns, a wide range of correlation scores
were observed. The correlation was greatest for
tissue-speciﬁc genes, with markedly lower corre-
lation scores observed for selectively and broadly
expressed genes (Table 2). Most genes judged to
be accurately expressed (highest correlation with
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Accuracy of Expression Profiles (% of genes with PCC ≥ 0.9 versus northern blots)
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Figure 2. Accuracy of expression proﬁling. Bar-plot depicts percentage of accurately proﬁled genes deﬁned by PCC ≥ 0.9
between the indicated method and Northern blots. Genes with restricted expression are prevalent (dc = double channel;
sc = single channel). The inner bars delineate the fraction of the total contribution from genes falling into three classes of
expression (speciﬁc to one tissue, selective expression in only two tissues, and broad)
Northern blot data) were tissue-speciﬁc (Figure 2).
Both RT-PCR and single-channel microarrays dis-
played less variation across the expression cat-
egories. When the data were classiﬁed accord-
ing to the magnitude of expression (based on
EST counts/gene), the highest correlations were
observed for genes with moderate expression levels
(data available on project website).
Discussion
As Northern blots have long served as a de facto
standard for gene expression analysis in molecular
biology, we created a literature-derived database
of results produced with a speciﬁc commercial
Northern blot to serve as a reference dataset. We
performed a quantitative comparison of diverse
expression proﬁling methods against the dbMTN
data to identify techniques well suited for high-
throughput analysis of human gene expression.
Correlations of the results with the published data
were consistently strongest for both cDNA and
oligonucleotide microarrays. The cross-platform
comparison provides a foundation for discussion
and demonstrates the value of the MTN reference
collection for the assessment of diverse approaches.
Creation of the dbMTN resource was depen-
dent upon the extraction of image ﬁles from elec-
tronic publications. The preponderance of MTN-
containing papers within three journals and the gen-
erous permission from the publishers to download
the ﬁles were essential for the initial construction.
Future expansion of dbMTN, and creation of sim-
ilar resources, will be facilitated by the expansion
of open-access policies for data in the scientiﬁc
literature [18].
There are several possible explanations for the
generally poor correlation observed between results
from different platforms. One could argue that
the correlation coefﬁcients are misrepresenting the
qualitative similarity of the data. This becomes par-
ticularly apparent during the analysis of broadly
expressed genes, where the lowest correlations are
observed. Pearson correlation coefﬁcients might
not be suited to compare quantitative readouts of a
broad set of genes captured with diverse expression
proﬁling techniques. To explore this possibility, a
range of different concordance measures have been
applied to assess the comparative performance of
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methods, all of which gave qualitatively similar
results to those reported (Reimers, unpublished).
For each platform, there are inherent character-
istics that inﬂuence the results. The E-Northerns
are limited by the available cDNA libraries, which
were generated from diverse RNA samples and,
in some cases, were prepared using normaliza-
tion procedures to increase transcript diversity. RT-
PCR is highly sensitive and has limited dynamic
range, potentially over-representing the relative
abundance of transcripts in tissues in which the
gene is expressed at low levels. The variety of
probes used in the different platform studies could
also introduce inconsistencies. For genes with alter-
natively expressed transcripts, the different probes
may hybridize to different subsets of the transcripts.
The protocols were speciﬁcally selected to be con-
sistent with standard laboratory practices, not nec-
essarily to maximize correlation.
An important point to consider is the source of
the RNA for cross-platform comparisons. In partic-
ular, we sought to maximize consistency of RNA
samples. The Northern blots were produced with
RNA pools generated with a deﬁned preparation
procedure by a single commercial provider (Clon-
Tech). All of the RNA samples used in this study
were obtained from ClonTech in order to mini-
mize technical variability. The RNA samples are
from pools of tissue obtained from multiple donors.
We believe the focus on using RNA from a sin-
gle source is an essential requirement to minimize
variability.
The magnitude of transcript concentration in the
RNA samples inﬂuences performance of proﬁling
methods in different ways. Gene expression proﬁles
from both oligonucleotide microarrays were most
similar to the Northern results for genes with
low transcript levels (Table 1). Sensitivity does not
appear to be prohibitive. However, we recognize
that genes available in the Northern blot database
may be biased in favour of those with higher levels
of expression. An alternative interpretation is that
the methods perform worse for genes with high
levels of expression, suggesting that some of the
methods are impacted by saturated signals. The
cDNA microarrays, on the other hand, performed
best for genes expressed at higher levels.
The choice of a primary expression proﬁl-
ing technique is dependent upon each scientist’s
research topic and targeted set of genes. We con-
clude, based on the sets of genes used in this
study, that oligonucleotide or cDNA microarrays
are the preferred expression proﬁling techniques
(among those examined) for the generation of data
that is most consistent with the standard of tradi-
tional Northern blots. Microarrays are well-suited
for comparisons of thousands of genes within two
RNA samples, while PCR-based approaches may
be preferable for in-depth analysis of a single gene
across many samples. As the correlation scores
observed between platforms are not encouraging,
we believe that an emphasis on multi-technique
validation of expression proﬁles is justiﬁed.
Several popular techniques were not addressed
in this study, including spotted oligonucleotide
arrays, quantitative PCR and SAGE. Quantitative
PCR, which has become a preferred technique for
gene-speciﬁc expression proﬁling, requires exten-
sive optimization for each primer pair [11], and
was judged to be cost-prohibitive in the scope
of this study. SAGE analysis, a sequencing ‘tag’-
based method, offers access to signiﬁcantly larger
data pools than the EST-based electronic North-
erns. While compatible SAGE libraries were not
available for our comparisons, a recent study
compared SAGE, E-Northerns and oligonucleotide
arrays [19]. The study, which focused on individual
tissues and selectively expressed genes, produced
correlation scores in the same range as those we
obtained for speciﬁcally expressed genes (Table 2).
Recently, arrays of long oligonucleotides have
emerged as a high-throughput option for expres-
sion proﬁling. Published results with long oligonu-
cleotide arrays are highly correlated with results
obtained using the Affymetrix platform [20]. The
pace of innovation of expression proﬁling technolo-
gies continues to offer new methods for consider-
ation.
The dbMTN collection is a valuable resource for
researchers assessing the performance of expres-
sion proﬁling methods. In order to facilitate fur-
ther exploration of the relative merits of diverse
techniques and protocols, we have provided an
extensive project website (http://www.cisreg.ca).
dbMTN and the data produced in this study should
provide fruitful opportunities to explore differ-
ent analysis procedures, and we strongly encour-
age others to perform similar studies or apply
their analysis procedures to the data we generated.
To encourage others to make quantitative com-
parisons for speciﬁc laboratory or computational
approaches, we will post relevant updates to the
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website detailing alternative methods or interpreta-
tions.
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